Could less chemo be just as good for stomach cancer?

NCT ID NCT03399110

First seen Jan 27, 2026 · Last updated Apr 25, 2026 · Updated 15 times

Summary

This study compares 4 months versus 6 months of chemotherapy (capecitabine and oxaliplatin) in 1024 stomach cancer patients who had surgery. The goal is to see if the shorter treatment works just as well to prevent cancer from coming back, while causing fewer side effects. Participants are adults aged 18-80 with stage II or III stomach cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Shenyang, China

  • Changhai Hospital

    Shanghai, China

  • Jiangsu Cancer Hospital

    Nanjing, China

  • Second Affiliated Hospital (Changzheng Hospital) of Naval Medical University

    Shanghai, China

  • Shanghai East Hospital

    Shanghai, China

  • Sun Yat-sen University Cancer Center

    Guangzhou, China

  • The First Affiliated Hospital of Anhui Medical University

    Hefei, China

  • The First Affiliated Hospital of University of Science and Technology of China

    Hefei, China

  • The First Affiliated Hospital of Wannan Medical College

    Wuhu, China

Conditions

Explore the condition pages connected to this study.